×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Regulation of phosphatase homologue of tensin protein expression by bone morphogenetic proteins in prostate epithelial cells.
21456062
2011
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
20729295
2010
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
We show that resveratrol inhibits AR transcriptional activity in both androgen-dependent and -independent prostate cancer cells.
20729295
2010
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
We show that resveratrol inhibits AR transcriptional activity in both androgen-dependent and -independent prostate cancer cells.
20729295
2010
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Thus, ERG has a distinct role in prostate cancer progression and cooperates with PTEN haploinsufficiency to promote progression of HGPIN to invasive adenocarcinoma.
19396168
2009
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
However, supportive evidence is limited to the effect of HER-2/neu that stimulates prostate cancer progression through activation of the androgen receptor .
19011039
2009
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
However, supportive evidence is limited to the effect of HER-2/neu that stimulates prostate cancer progression through activation of the androgen receptor .
19011039
2009
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
19081794
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer .
18829485
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Effects of manganese superoxide dismutase silencing on androgen receptor function and gene regulation: implications for castration-resistant prostate cancer .
18829485
2008
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774
2007
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Integrative molecular concept modeling of prostate cancer progression.
17173048
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells.
17003774
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
17141945
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
Cellular changes in prostate cancer cells induced by intermittent androgen suppression.
17141945
2007
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide.
16934689
2006
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide.
16934689
2006
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.
16421604
2006
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway.
16998812
2006
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway.
16998812
2006
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
These results reveal a potentially critical function of AR in androgen-independent PCa that is distinct from its previously described transcriptional or nontranscriptional functions.
16877366
2006
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
These results reveal a potentially critical function of AR in androgen-independent PCa that is distinct from its previously described transcriptional or nontranscriptional functions.
16877366
2006
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Although the androgen receptor (AR ) is suggested to play an important role in prostate cancer progression even after the androgen ablation, limited tissue availability for molecular studies and small numbers of human prostate cancer cell lines have restricted prostate cancer research.
16266977
2005
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Therapeutic
CTD_human
Endocrine approaches in the therapy of prostate carcinoma.
15790600
2005
×
Entrez Id:
367
Gene Symbol:
AR
AR
Malignant neoplasm of prostate
1.000
Biomarker
CTD_human
Endocrine approaches in the therapy of prostate carcinoma.
15790600
2005